Usefulness of the measurement of plasma neutrophil gelatinase-associated lipocalin as a biomarker for predicting prognosis in hospitalized patients with pneumonia

S. Kim (Seoul, Republic of Korea), J. Min (Seoul, Republic of Korea), T. Park (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), J. Moon (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea), J. Sohn (Seoul, Republic of Korea), H. Yoon (Seoul, Republic of Korea)

Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Session: Predicting the future: biomarkers of respiratory infection
Session type: Thematic Poster
Number: 2613
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Kim (Seoul, Republic of Korea), J. Min (Seoul, Republic of Korea), T. Park (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), J. Moon (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea), J. Sohn (Seoul, Republic of Korea), H. Yoon (Seoul, Republic of Korea). Usefulness of the measurement of plasma neutrophil gelatinase-associated lipocalin as a biomarker for predicting prognosis in hospitalized patients with pneumonia. 2613

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patients
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1807-1809
Year: 2014


Human neutrophil gelatinase-associated lipocalin: A new biomarker in asthma-COPD overlap syndrome
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Usefulness of C-reactive protein and procalcitonin in predicting mortality in community-acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008


LSC - 2019 - Neutrophil gelatinase-associated lipocalin and IL-6 – markers predictors for exacerbations in Asthma- COPD overlap, compared to COPD and Asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016

Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012


Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Neutrophil number, cytokine and elastase postoperative increase as probable pneumonia predictor
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008

Circulating total leptin as a diagnostic and prognostic biomarker in sepsis
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019


Measurements usefulness of serum C-reactive protein for management of adult community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009

Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007


The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019


Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007


Serum CC16 is a potential predictor for IPF diagnosis and prognosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients
Source: International Congress 2017 – Sepsis, infections, ARDS and beyond
Year: 2017


Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Diagnostic and prognostic value of C-reactive protein in community-acquired pneumonia hospitalized patients
Source: Eur Respir J 2004; 24: Suppl. 48, 188s
Year: 2004

C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 545s
Year: 2005